stock
PTHS · Pelthos Therapeutics Inc.
What Pelthos Therapeutics Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live PTHS price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on PTHS.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 3,828,469 as of 2026-08-10 (XBRL frame )
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- -133.4%
- Net
- -199.5%
Returns
- ROE
- —
- ROA
- -62.9%
Health
- Current ratio
- 2.0x
- Debt/equity
- —
Deep value
- NCAV
- -$75.50M
- NCAV per share
- -$19.72
- Price/NCAV
- Locked
- NNWC
- -$93.07M
- NNWC per share
- -$24.31
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $15.60M | —Gross profit: unreported by this company. | -$17.32M | -$23.42M | 10-Q filed 2026-08-13 |
| 2026-03-31 | $10.91M | —Gross profit: unreported by this company. | -$13.09M | -$25.07M | 10-Q filed 2026-08-13 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | $16.50M | —Gross profit: unreported by this company. | -$12.00M | -$21.66M | 10-K filed 2026-03-19 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2025-09-30 | $294,000 | —Gross profit: unreported by this company. | -$15.36M | -$16.24M | 10-Q filed 2025-11-13 |
| 2025-06-30 | $0 | —Gross profit: unreported by this company. | -$3.23M | -$3.45M | 10-Q filed 2026-08-13 |
| 2025-03-31 | $0 | —Gross profit: unreported by this company. | -$1.83M | -$1.97M | 10-Q filed 2026-08-13 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | — | —Gross profit: unreported by this company. | -$1.82M | -$1.93M | 10-K filed 2026-03-19 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2024-09-30 | — | —Gross profit: unreported by this company. | -$2.05M | -$1.70M | 10-Q filed 2025-11-13 |
- Assets
- $137.36M
- Equity
- -$1.50M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $16.80M | -$32.43M | -$43.32M | -$22.69M |
| 2024-12-31 | $0 | -$7.57M | -$7.96M | -$5.79M |
| 2023-12-31 | — | -$6.86M | -$7.38M | — |
| 2022-12-31 | — | -$2.32M | -$2.46M | — |
Company filings
since Mon Feb 2 · 1 offering filing in 12 months
events
Executive or director change, Shareholder vote results
Executive or director changeShareholder vote resultsOct 18-KResults, Regulation FD disclosure
ResultsRegulation FD disclosureAug 138-KPast results not reliable
Past results not reliableAug 138-KRegulation FD disclosure
Regulation FD disclosureMay 288-KAuditor change, Executive or director change
Auditor changeExecutive or director changeMay 218-KResults, Regulation FD disclosure
ResultsRegulation FD disclosureMay 148-K
5% owners ()
Ikarian Capital, LLC
Stake update
3i, LP
Stake update
Ikarian Capital, LLC
Stake update
3i, LP
Stake update
Ikarian Capital, LLC
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
No insider buys or sales filed in the last 90 days.
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
None of the tracked funds held this at their last 13F.
News
Stories that named PTHS, and the market events around them.
Sign in to see thisBoard
The PTHS board could not be loaded.
Retry the PTHS boardnakagai
Signals on PTHS come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the PTHS board